Kendall Law Group, led by former federal judge Joe Kendall, is investigating certain officers and directors of Merge Healthcare (NASDAQ: MRGE) on behalf of shareholders to determine whether the officials breached their fiduciary duties to shareholders in the proposed sale to an affiliate of IBM. According to the agreement, Merge shareholders will receive $7.13 per share in cash, for a total transaction value of $1 billion. The national securities firm's investigation seeks to determine whether Merge Healthcare and its Board breached their fiduciary duties by engaging in self-dealing, failing to maximize the value of the Company, failing to disclose all material benefits and costs, and failing to obtain the best possible consideration for the shareholders. If you currently own shares of Merge Healthcare and want to know more about your rights, you are encouraged to contact Jamie McKey at the Kendall Law Group at 877-744-3728 or by email at email@example.com to learn more about your legal rights as a shareholder. There is no cost or obligation to you. Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in nationwide complex securities litigation. The firm has been counsel in numerous shareholder derivative and securities class action lawsuits on behalf of shareholders in state and federal courts throughout the United States.